GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Charles River Laboratories International Inc (NYSE:CRL) » Definitions » Price-to-Free-Cash-Flow

Charles River Laboratories International (Charles River Laboratories International) Price-to-Free-Cash-Flow

: 31.94 (As of Today)
View and export this data going back to 2000. Start your Free Trial

As of today (2024-04-19), Charles River Laboratories International's share price is $226.78. Charles River Laboratories International's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $7.10. Hence, Charles River Laboratories International's Price-to-Free-Cash-Flow Ratio for today is 31.94.

The historical rank and industry rank for Charles River Laboratories International's Price-to-Free-Cash-Flow or its related term are showing as below:

CRL' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 11.46   Med: 21.98   Max: 50.93
Current: 31.93

During the past 13 years, Charles River Laboratories International's highest Price-to-Free-Cash-Flow Ratio was 50.93. The lowest was 11.46. And the median was 21.98.

CRL's Price-to-Free-Cash-Flow is ranked worse than
61.54% of 91 companies
in the Medical Diagnostics & Research industry
Industry Median: 27.86 vs CRL: 31.93

Charles River Laboratories International's Free Cash Flow per Share for the three months ended in Dec. 2023 was $2.78. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $7.10.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of Charles River Laboratories International was 23.50% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was -1.80% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 1.50% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 7.60% per year.

During the past 13 years, Charles River Laboratories International's highest 3-Year average Free Cash Flow per Share Growth Rate was 48.60% per year. The lowest was -31.90% per year. And the median was 14.40% per year.


Charles River Laboratories International Price-to-Free-Cash-Flow Historical Data

The historical data trend for Charles River Laboratories International's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Array ( [0] => - [1] => - [2] => - [3] => - [4] => - [5] => 22.30 [6] => 33.27 [7] => 36.42 [8] => 37.90 [9] => 33.29 )
Charles River Laboratories International Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.30 33.27 36.42 37.90 33.29

Charles River Laboratories International Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Free-Cash-Flow Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 37.90 37.62 37.32 27.38 33.29

Competitive Comparison

For the Diagnostics & Research subindustry, Charles River Laboratories International's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Charles River Laboratories International Price-to-Free-Cash-Flow Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, Charles River Laboratories International's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Charles River Laboratories International's Price-to-Free-Cash-Flow falls into.



Charles River Laboratories International Price-to-Free-Cash-Flow Calculation

Charles River Laboratories International's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=226.78/7.1
=31.94

Charles River Laboratories International's Share Price of today is $226.78.
Charles River Laboratories International's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $7.10.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Charles River Laboratories International  (NYSE:CRL) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Charles River Laboratories International Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Charles River Laboratories International's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Charles River Laboratories International (Charles River Laboratories International) Business Description

Traded in Other Exchanges
Address
251 Ballardvale Street, Wilmington, MA, USA, 01887
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Executives
Victoria L Creamer officer: EVP & Chief People Officer 164 PINE HILL ROAD, NEW FAIRFIELD CT 06812
Joseph W Laplume officer: EVP, Corp Strategy & Develop 251 BALLARDVALE STREET, WILMINGTON MA 01887
Birgit Girshick officer: Corporate Executive VP 251 BALLARDVALE STREET, WILMINGTON MA 01887
James C Foster director, officer: President and CEO 251 BALLARDVALE ST, WILMINGTON MA 01887
Richard F Wallman director HONEYWELL, 101 COLUMBIA ROAD, MORRISTOWN NJ 07962
William D Barbo officer: Corporate Executive VP & CCO 251 BALLARDVALE STREET, WILMINGTON MA 01887
Michael Gunnar Knell officer: CSVP&Chief Accounting Officer BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
George Massaro director
Shannon M Parisotto officer: CEVP, Disc & Safety Assessment 251 BALLARDVALE ST, WILMINGTON MA 01887
Flavia Pease officer: Corporate Executive VP 251 BALLARDVALE STREET, WILMINGTON MA 01887
David Ross Smith officer: Corporate Executive VP & CFO 251 BALLARDVALE STREET, WILMINGTON MA 01887
Deborah Turner Kochevar director 251 BALLARDVALE STREET, WILMINGTON MA 01887
Milne George M Jr director
Stephen D Chubb director C/O MATRITECH INC, 330 NEVADA STREET, NEWTON MA 02460
George Llado director 251 BALLARDVALE STREET, WILMINGTON MA 01887